Journal article icon

Journal article

The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.

Abstract:

OBJECTIVES: This study sought to compare the 1-year safety and efficacy of Cypher Select or Cypher Select Plus (Cordis Corporation, Bridgewater, New Jersey) sirolimus-eluting stents (SES) with the treatment of bare-metal stents (BMS) and drug-eluting stent (DES) in-stent restenosis (ISR) in nonselected, real-world patients. BACKGROUND: There is paucity of consistent data on DES for the treatment of ISR, especially, DES ISR. METHODS: The e-SELECT (Multicenter Post-Market Surveillance) registry...

Expand abstract

Actions


Access Document


Publisher copy:
10.1016/j.jcin.2011.09.016

Authors


Abizaid, A More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, RDM, Cardiovascular Medicine
Bartorelli, AL More by this author
Expand authors...
Journal:
JACC. Cardiovascular interventions
Volume:
5
Issue:
1
Pages:
64-71
Publication date:
2012-01-05
DOI:
EISSN:
1876-7605
ISSN:
1936-8798
URN:
uuid:00c5c297-5a7a-4254-b786-56e1ac3ef10d
Source identifiers:
245339
Local pid:
pubs:245339

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP